Left atrial appendage occlusion for stroke prevention in diabetes mellitus patients with atrial fibrillation: Long‐term results: 合并心房颤动的糖尿病患者通过左心耳封堵术 …
…, B Kapelak, D Lakkireddy, K Bartus - Journal of …, 2019 - Wiley Online Library
… However, in nearly 40% of patients with AF, OAC is contraindicated.7 Moreover, DM
patients taking non-vitamin K oral anticoagulants have a greater absolute thromboembolic risk …
patients taking non-vitamin K oral anticoagulants have a greater absolute thromboembolic risk …
探討新型口服抗凝血劑用於心房顫動病人的有效性及安全性
MC Lee - 高雄醫學大學藥學系碩士在職專班學位論文, 2018 - airitilibrary.com
… Background Atrial fibrillation (AF) patients have a higher risk … Non-vitamin K antagonist
oral anticoagulants (NOACs) had … However, since some studies indicated that Asian people …
oral anticoagulants (NOACs) had … However, since some studies indicated that Asian people …
[PDF][PDF] NOACs 用药教育对心房颤动患者抗凝认知水平的影响
李浩， 施芳红， 顾智淳， 沈珑， 张顺国， 刘晓琰 - 世界临床药物, 2019 - jwph.com.cn
… impairment in atrial fibrillation patients receiving nonvitamin K antagonist oral anticoagulants:
a … of blonanserin in healthy Chinese subjects[J]. Eur J Clin Pharmacol, 2018, 74(1): 61-67. …
a … of blonanserin in healthy Chinese subjects[J]. Eur J Clin Pharmacol, 2018, 74(1): 61-67. …
心房顫動合併冠狀動脈疾病抗血栓治療
雷青熒， 蔡慈貞， 溫明賢 - 臺灣臨床藥學雜誌, 2019 - airitilibrary.com
… TAT duration will be provided in two ongoing non-vitamin K antagonist oral anticoagulant
(NOAC) in AF trials. Key words: Atrial Fibrillation, Percutaneous Coronary Intervention, Triple …
(NOAC) in AF trials. Key words: Atrial Fibrillation, Percutaneous Coronary Intervention, Triple …
心房顫動患者使用新型口服抗凝血劑不同劑量之療效及安全性評估
李敏慈 - 國立臺灣大學流行病學與預防醫學研究所學位論文, 2020 - airitilibrary.com
… Non vitamin K antagonist oral anticoagulants (NOACs) including dabigatran, apixaban, …
new oral anticoagulants have been approved to treat patients with non-valvular atrial fibrillation(…
new oral anticoagulants have been approved to treat patients with non-valvular atrial fibrillation(…
口服抗凝剂在非瓣膜性房颤伴慢性肾功能不全患者中的应用进展
李欣， 刘璐， 柳志红， 赵智慧， 罗勤， 赵青 - 协和医学杂志, 2022 - xhyxzz.pumch.cn
… better patient compliance. However, all the non-vitamin K antagonist oral anticoagulants are
… and thus their administration in patients with atrial fibrillation and chronic renal insufficiency …
… and thus their administration in patients with atrial fibrillation and chronic renal insufficiency …
[HTML][HTML] 非瓣膜性心房颤动口服抗凝药物临床应用研究进展
朱虹， 赵德斌， 施蕾， 李红 - Advances in Clinical Medicine, 2024 - hanspub.org
… 非瓣膜性心房颤动(nonvalvular atrial fibrillation, NVAF)是AF中… direct oral anticoagulants
(DOACs) over vitamin K antagonists … 非维生素K拮抗剂口服抗凝药物(non-vitamin K antagonist oral …
(DOACs) over vitamin K antagonists … 非维生素K拮抗剂口服抗凝药物(non-vitamin K antagonist oral …
[PDF][PDF] 比較非維生素K 拮抗劑口服抗凝血劑與warfarin 在心房顫動和糖尿病患者中對糖尿病相關併發症及嚴重低血糖風險的影響
黃暉凱 - 2024 - tdr.lib.ntu.edu.tw
… non-vitamin K antagonist oral anticoagulants (NOACs) use and warfarin use due to their
varying effects on vitamin K function. … populations worldwide, atrial fibrillation has emerged as a …
varying effects on vitamin K function. … populations worldwide, atrial fibrillation has emerged as a …
心房颤动患者服用利伐沙班致出血的研究进展
姚娟 - Advances in Clinical Medicine, 2023 - hanspub.org
… Abstract: Atrial fibrillation is a common arrhythmia, the new oral anticoagulants (NOACs) …
, becomes the preferred treatment of patients with atrial fibrillation, the use of rivaroxaban is …
, becomes the preferred treatment of patients with atrial fibrillation, the use of rivaroxaban is …
探討口服抗凝血藥物於腦內出血後的使用適當性和時機
童郁琇， 林宏昇， 戴慶玲 - 臺灣臨床藥學雜誌, 2019 - airitilibrary.com
… Oral anticoagulants (OACs) have been proven effectively to prevent stroke or systemic
embolism in patients with atrial fibrillation … 凝血藥物(nonvitamin K antagonist oral anticoagulants, …
embolism in patients with atrial fibrillation … 凝血藥物(nonvitamin K antagonist oral anticoagulants, …